SCHEMBL29514967

SCHEMBL29514967

CCN1CCN(c2ccnc(Nc3ncc(F)c(-c4sc5c(nc(C)n5C(C)C)c4C)n3)c2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCND1 P24385 19/20 1.00
CDK4 P11802 14/20 1.00
CDK6 Q00534 9/20 0.71
CIT O14578 1/20 0.50
GAK O14976 1/20 0.50
DYRK3 O43781 1/20 0.50
CCNT1 O60563 1/20 0.50
STK16 O75716 1/20 0.50
CCNK O75909 1/20 0.50
STK10 O94804 1/20 0.50
PRKD3 O94806 1/20 0.50
ABCB11 O95342 1/20 0.50
MAP4K4 O95819 1/20 0.50
CCNE2 O96020 1/20 0.50
EGFR P00533 1/20 0.50
NTRK1 P04629 1/20 0.50
PRKCB P05771 1/20 0.50
CDK1 P06493 1/20 0.50
PIM1 P11309 1/20 0.50
CCNB1 P14635 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24322192 1.00 CCND1 (1.00) CCND1CDK4CDK6CITGAK
SCHEMBL24322347 0.89 CCND1 (0.84) CCND1CDK4CDK6CCNA2CDK2
SCHEMBL29514918 0.89 CCND1 (0.84) CCND1CDK4CDK6CCNA2CDK2
SCHEMBL29515160 0.85 CCND1 (0.75) CCND1CDK4CDK6CITGAK
SCHEMBL24322997 0.85 CCND1 (0.75) CCND1CDK4CDK6CITGAK
SCHEMBL24322185 0.85 CCND1 (0.75) CCND1CDK4CDK6CITGAK
SCHEMBL29515035 0.83 CCND1 (1.00) CCND1CDK4CDK6CITGAK
SCHEMBL25284830 0.83 CCND1 (1.00) CCND1CDK4CDK6CITGAK
SCHEMBL25284787 0.83 CCND1 (0.76) CCND1CDK4CDK6CCNA2CDK2
SCHEMBL29514856 0.83 CCND1 (0.76) CCND1CDK4CDK6CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4214213-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS Prelude Therapeutics, Incorporated (US) 2023-07-26 EP disclosed
WO-2022061273-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS, INCORPORATED (US) 2022-03-24 WO disclosed